These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6341140)

  • 1. Residual B cell function in diabetic children as determined by urinary C-peptide.
    Aurbach-Klipper J; Sharph-Dor R; Heding LG; Karp M; Laron Z
    Diabetologia; 1983 Feb; 24(2):88-90. PubMed ID: 6341140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on urinary C-peptide excretion in normal children and children with insulin-dependent diabetes mellitus].
    Kusayanagi T
    Nihon Ika Daigaku Zasshi; 1989 Apr; 56(2):103-22. PubMed ID: 2659621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine C-peptide, beta-cell function, and insulin requirement.
    Rappaport EB; Ulstrom RA; Etzwiler DD; Fife D; Hedlund BE; Steffes MW
    Am J Dis Child; 1980 Dec; 134(12):1129-33. PubMed ID: 7004175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity and reproducibility of urinary C-peptide as estimate of islet B-cell function in insulin-treated diabetes.
    Gjessing HJ; Matzen LE; Faber OK; Frøland A
    Diabet Med; 1989; 6(4):329-33. PubMed ID: 2524338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-peptide/creatinine ratio in early morning urine as an indicator of residual B-cell function in insulin-dependent diabetes.
    Sasaki N; Miyamoto S; Niimi H; Nakajima H
    Acta Paediatr Jpn; 1991 Jun; 33(3):375-80. PubMed ID: 1785335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
    Gerö L; Korányi L; Tamás G
    Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [C-peptide excretion in 24 hours-urine as an indicator of B-cell residual function in children and adolescents with type-I-diabetes (author's transl)].
    Zick R; Hürter P; Lange P; Mitzkat HJ
    Monatsschr Kinderheilkd; 1982 Apr; 130(4):209-14. PubMed ID: 7048077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assay of C-peptide in diabetes in children and adolescents].
    Jos J; Kestenbaum S
    Ann Med Interne (Paris); 1984; 135(6):416-9. PubMed ID: 6391322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of B-cell function by the urinary excretion rate of C-peptide in diabetic patients: comparison with C-peptide response to glucagon and to a mixed meal.
    Pasquali R; Buratti P; Biso P; Patrono D; Capelli M; Pasqui F; Melchionda N
    Diabete Metab; 1987 Feb; 13(1):44-51. PubMed ID: 3552774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of residual B-cell function related to age at onset and genetic profile in newly diagnosed type I diabetics.
    Giordano C; Galluzzo A; Pantò F; Caruso C; Bompiani G
    Acta Diabetol Lat; 1987; 24(4):317-23. PubMed ID: 3326380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behavior of urinary C-peptide in type I diabetic subjects].
    Scattoni M; Matteucci L; Malagnino A; Campagna A; Bartolozzi M; Pagliuchi M; Martelli F
    Minerva Pediatr; 1986 Oct; 38(20):911-5. PubMed ID: 3796554
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary C-peptide: a useful tool for evaluating the endogenous insulin reserve in cohort and longitudinal studies of diabetes in childhood.
    de Beaufort CE; den Boer NC; Bruining GJ; Eilers GA; van Strik R; Weterings T
    Ann Clin Biochem; 1988 Sep; 25 ( Pt 5)():552-9. PubMed ID: 3069047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis.
    Wallensteen M; Dahlquist G; Persson B; Landin-Olsson M; Lernmark A; Sundkvist G; Thalme B
    Diabetologia; 1988 Sep; 31(9):664-9. PubMed ID: 3069534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.
    Gjessing HJ; Matzen LE; Faber OK; Frøland A
    Diabetologia; 1989 May; 32(5):305-11. PubMed ID: 2666217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of urinary C-peptide excretion in children with insulin-dependent diabetes mellitus.
    Huttunen NP; Knip M; Käär ML; Puukka R; Akerblom HK
    Acta Paediatr Scand; 1989 Mar; 78(2):271-7. PubMed ID: 2648764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual beta-cell function and microvascular complications in type 1 diabetic patients.
    Gomes MB; Goncalves MF; Neves R; Cohen C; Albanesi FM
    Braz J Med Biol Res; 2000 Feb; 33(2):211-6. PubMed ID: 10657061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary C-peptide excretion at onset of insulin dependent diabetes mellitus in children.
    Ivarsson SA; Johansson E; Nilsson KO; Thorell JI
    Acta Paediatr Scand; 1987 Jul; 76(4):608-11. PubMed ID: 3630678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of residual beta-cell function on the development of diabetic retinopathy.
    Madsbad S; Lauritzen E; Faber OK; Binder C
    Diabet Med; 1986 Jan; 3(1):42-5. PubMed ID: 2951134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [C-peptide immunoreactivity CPR), urine CPR, beta-cell function (author's transl)].
    Teshirogi T
    Nihon Ika Daigaku Zasshi; 1981 Jun; 48(3):333-8. PubMed ID: 7028779
    [No Abstract]   [Full Text] [Related]  

  • 20. Residual B-cell function in type 1 (insulin-dependent) diabetes mellitus: its relation to clinical and metabolic features.
    Bonora E; Coscelli C; Butturini U
    Acta Diabetol Lat; 1984; 21(4):375-83. PubMed ID: 6397028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.